Tuesday, March 12, 2019

insulin research trial in Reno: are you interested?


If you are an adult between ages 18 and 65 living with type 1 diabetes you may be eligible to take part in the GAZELLE clinical research trial. This trial will look at an investigational fast-acting insulin to see if it works as effectively as an existing fast-acting insulin already being used to treat diabetes. Trial-related medications, procedures, equipment, and supplies will be provided at no cost; health insurance is not required to participate. Ready to learn more? Please read on.
The GAZELLE trial aims to understand if an investigational medication is as clinically effective as a currently-approved fast-acting insulin replacement, with the hope of improving patient access with more options for treating type 1 diabetes.
We are looking for people ages 18 to 65 who, among other things:
  Have been diagnosed with type 1 diabetes for at least six months   Are on a stable once daily dose of basal Lantus or Toujeo injections and multiple daily bolus NovoLog injections for at least 3 months prior to screening
  Have not used insulin pump therapy or any anti-diabetic medications other than trial-approved insulins within the last 3 months
  Have not used animal insulin (such as from a cow or pig) within the last 2 years
  Have not used a regular immunomodulator therapy within the last year
  Are able and willing to self-monitor blood glucose, including up to 7 times per day on selected days
Please contact me if you are interested in learning more about this clinical trial.